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Abstract
Background: The p49/STRAP (or SRFBP1) protein was recently identified in our laboratory as a
cofactor of serum response factor that contributes to the regulation of SRF target genes in the
heart.
Results: In the present study, we report that NDUFAB1, a nuclear encoded subunit of NADH
dehydrogenase, represented the majority of the cDNA clones that interacted with p49/STRAP in
multiple screenings using the yeast two-hybrid system. The p49/STRAP and NDUFAB1 proteins
interacted and co-localized with each other in the cell. The p49/STRAP protein contains four classic
nuclear localization sequence motifs, and it was observed to be present predominantly in the
nucleus. Overexpression of p49/STRAP altered the intracellular level of NAD, and reduced the
NAD/NADH ratio. Overexpression of p49/STRAP also induced the deacetylation of serum
response factor.
Conclusion: These data suggest that p49/STRAP plays a role in the regulation of intracellular
processes such as cardiac cellular metabolism, gene expression, and possibly aging.
Background
A novel protein, p49/STRAP, was recently identified in
our laboratory [1]. The initial observations indicated that
p49/STRAP is a cofactor of serum response factor (SRF)
contributing to the regulation of SRF target genes in the
heart. This gene was later named by The Human Genome
Organization (HUGO) as SRFBP1 based on our initial
finding that p49/STRAP binds to SRF. The p49/STRAP
mRNA and protein are expressed in multiple tissues,
including heart, brain, liver, skeletal muscle and kidney.
An increase of p49/STRAP expression has been observed
in the myocardium of human and mouse with advancing
age, and also in transgenic mice suffering from cardiomy-
opathy [1,2].
Our previous studies suggested that the expression of a
number of cardiac genes are regulated by a protein com-
plex containing SRF and it's multiple binding proteins,
including p49/STRAP and Zipzap/p200 [1-3]. We had
noticed that the protein complexes obtained by immuno-
precipitation assays with either p49/STRAP or SRF anti-
body contained more components than we had
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anticipated, suggesting that additional proteins may be
present in the complex [1-3]. The p49/STRAP protein
interacts directly with the SRF transcriptional activation
domain. Therefore, it is possible that a protein complex
formed around this domain or those proteins that bind to
p49/STRAP may have a significant effect on SRF activa-
tion. In an attempt to determine the identity of these puta-
tive proteins, we used p49/STRAP protein fragments as
bait in the yeast two-hybrid system. We found that
NDUFAB1, a subunit of NADH dehydrogenase (a nuclear
encoded subunit of mitochondrial Complex I), repre-
sented the majority of cDNA clones interacting with p49/
STRAP in the multiple screenings. Overexpression of p49
changed the intracellular NAD/NADH ratio and reduced
the amount of acetylated-SRF protein. Therefore, p49 may
play a role in the process of protein acetylation and
deacetylation, thereby modulating transcriptional regula-
tion.
Methods
Yeast Two-hybrid Screening and Bioinformatic Analysis
Yeast two-hybrid screening was performed as previously
described [1]. Briefly, one "bait" construct containing the
N-terminus (residues 1–256) and another one containing
the C-terminus (residues 250–427) of the p49/STRAP
protein were used to screen cDNA libraries generated from
a human heart and Hela cells (Clontech). A total of three
separate screenings was performed. Positive target cDNA
clones were subjected to a series of analyses according to
the manufacturer's instruction manual. The final positive
clones were sequenced and their sequences were com-
pared with the Genbank nucleotide database.
Bioinformatics Analysis
The p49/STRAP and NDUFAB1 sequences were subjected
to analyses using web-based and/or freely-downloaded
bioinformatic tools, including "PSORT II" [4], "iPSORT"
[5], "WoLF PSORT", "BaCelLo" [6], "pTARGET" [7],
"CELLO version 2" [8], "Golgi Localization Predictor" [9],
"HSLPred" [10], "GoCore" and "SignalP" [11].
Cloning of Full-length Coding Region Sequence of 
NDUFAB1 gene
The majority of the cDNA clones interacting with the N-
terminal bait of the p49/STRAP protein in the yeast two-
hybrid screening matched a single gene in the GenBank
database, NDUFAB1, which is a subunit of NADH dehy-
drogenase (OMIM 25010; EC 1.6.5.3). The full-length
coding region of the human NDUFAB1 gene was ampli-
fied by PCR using a human heart cDNA sample (Clon-
tech) and then subcloned into the expression vectors.
Plasmid Constructs
A pcDNA3-Flag-NDUFAB1 construct was generated by
ligating the NDUFAB1 coding region in frame with Flag
into the pcDNA3-Flag vector. A pcDNA3-mCherry-
NDUFAB1 construct was generated by ligating the
mCherry red fluorescent protein (RFP, a gift from Dr.
Roger Tsien, University of California, San Diego) in frame
with NDUFAB1 into the pcDNA3 vector. The p49/STRAP-
EGFP fusion protein construct and the pcDNA3-HA-p49/
STRAP construct were generated as previously reported
[1]. All the plasmid constructs were subjected to sequenc-
ing analysis to verify the open reading frame sequence.
Generation of Recombinant Adenoviruses
The p49/STRAP recombinant adenovirus was generated
using the AdEasy system, a generous gift from Dr. Vogel-
stein (The Johns Hopkins Oncology Center, Baltimore)
[12]. The generation, purification and titration of the
recombinant adenoviruses Ad-EGFP and Ad-p49/STRAP
were performed according to the protocol described by He
et al. [12].
Tissue Culture and Transfection Assays
The H9C2 cells, NIH3T3 cells and neonatal rat cardiac
myocytes were cultured as previously described [1,13,14].
Transient transfection was carried out using the desired
expression plasmid constructs and the Lipofectamine
2000 reagent (Invitrogen). At approximately 4 hr after the
transfection was initiated, cells were placed in DMEM
medium containing 10% newborn bovine serum and
incubated at 37°C overnight.
Co-immunoprecipitation and Western Blotting
The expression plasmid constructs containing p49/STRAP
and NDUFAB1 were cotransfected into NIH3T3 cells by
using Lipofectamine 2000 (Invitrogen) as previously
described [1]. At 48 h after the transfection, cells were har-
vested, and the whole-cell lysate was isolated. The co-
immunoprecipitation and Western blotting were carried
out as previously described [1]. Antibodies that were
employed included monoclonal antibodies HA.11 (Cov-
ance), FLAG (M2, Sigma), SRF (Abcam) and an anti-
acetyl-Lysine antibody (clone 4G12, Upsate); polyclonal
antibodies HA (Santa Cruz), Flag (Sigma), a SRF antibody
which recognizes the C-terminus of SRF protein (Santa
Cruz) and p49/Strap [1].
Fluorescence Microscopy
The expression plasmids "EGFP-p49/STRAP" and
"mCherry-NDUFAB1" were used for the transfection. At
approximately 24, 48, and 72 hours after transfection, the
expression of EGFP-p49/STRAP and mCherry-NDUFAB1
were examined by fluorescence microscopy using a Nikon
Eclipse E600 equipped with CoolSNAP-ES digital camera
and MetaVue 6.2 software.
The intensity of fluorescence was measured using the
"ImageJ 1.37" program (National Institutes of Health,BMC Cell Biology 2008, 9:8 http://www.biomedcentral.com/1471-2121/9/8
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Bethesda, MD). Background noise was subtracted. The
area of, and total fluorescence signal from, nuclear and
non-nuclear cellular regions were measured separately.
The cytoplasm superior and inferior to the nucleus was
estimated to have a p49/STRAP concentration similar to
that in the perinuclear region. It was further estimated that
the cytoplasmic overlay on the nucleus was thinner than
that of the surrounding region. For these reasons, the total
fluorescence in the nuclear region was estimated to con-
sist of p49 in the nucleus proper, and an amount of p49
represented by the product of the intensity of signal in the
extranuclear region and the area of the nucleus itself.
Nuclear p49 signal = Total Nuclear Signal - (Extranuclear 
Signal Intensity × Nuclear Area)
In addition, the cytosolic fraction of p49 was estimated to
be a ratio of cytosolic signal to the total signal.
NAD/NADH Assay
The H9C2 cells were used for the assessment of NAD/
NADH ratio in response to p49/STRAP gene expression.
The NAD assay was performed using a protocol modified
from the methods described by Zerez et al. [15] as well as
Bernofsky and Swan [16], in which H9C2 cells were
infected with 25 MOI of recombinant adenoviruses 48
hours before the assay was performed. The values are
expressed as means ± S.D. A p value of less than 0.05 was
considered to be significant.
Results
NDUFAB1 is a p49/STRAP binding protein
p49/STRAP was first identified as a transcription cofactor
of SRF [1]. To explore a broad spectrum of potential p49/
STRAP binding proteins, we employed a yeast two-hybrid
system in which two overlapping cDNA fragments cover-
ing the entire p49 protein were used as baits to screen two
human cDNA libraries. The utilization of separate bait
fragments, p49/STRAP N-terminus (p49-N) and p49/
STRAP C-terminus (p49-C), was intended to maximize
the screening efficiency and to distinguish the binding
proteins that may selectively interact with the different
parts of the p49 protein.
A human heart cDNA library derived from terminally dif-
ferentiated cardiomyocytes and non-cardiomyocyte cells,
and a Hela cell cDNA library generated from highly prolif-
erating tumor cells were selected to represent the cells
with different biological features.
When the human heart cDNA library was screened with
p49-N bait, 42 out of 44 (95%) of the final target clones
that were analyzed matched a single gene, NDUFAB1,
which is a subunit of NADH dehydrogenase I. When the
Hela cell cDNA library was screened, 8 out of 20 (40%)
clones matched NDUFAB1 (table 1). Since NDUFAB1
cDNA clones were the main p49/STRAP interacting pro-
tein in two screenings with p49-N bait, we wondered
whether NDUFAB1 could also be a major target for the
p49-C bait screening.
In a third screening, the p49-C bait plasmid was used to
screen the Hela cell library and 41 final target clones were
analyzed. However, no clone matched to NDUFAB1 (0%)
(table 1). These data indicate that NDUFAB1 protein
selectively binds the N-terminus of p49/STRAP (figure
1a).
To confirm the interaction between p49/STRAP and
NDUFAB1 in the mammalian cells, we performed immu-
noprecipitation assays. As shown in figure 1b, immuno-
precipitation of the endogenous p49/STRAP protein with
anti-p49 antibody co-precipitated the NDUFAB1 protein.
The expression of NDUFAB1 plasmid construct did not
change the level of p49/STRAP protein in the cells (figure
1c).
Bioinformatics analysis of p49/STRAPand NDUFAB1
To determine the functional and conserved domains in
p49/STRAP and NDUFAB1, we used web-based bioinfor-
matic tools to analyze the protein sequences of these two
genes.
Analysis of p49/STRAP showed that it contains as many as
four classic NLS motifs (figure 2). Two bipartite NLS
Cytosolic p49 (%)
100   Cytosolic Signal
Cytosolic   Nucle
=
×
+ ( a ar  Signal )
Table 1: The NDUFAB1 protein selectively binds to the N-terminus of p49 protein (p49-N).
Origin of cDNA Library Screening bait Clones positive for NDUFAB1 Main target
Haert p49-N 95% NDUFAB1
Hela p49-N 40% NDUFAB1
Hela p49-C 0% Other
Three separate yeast two-hybrid screenings were performed using p49-N and p49-C as bait, respectively. When p49-N was used to screen human 
heart cDNA library, 42 out of 44 (95%) of the positive clones that interacted with p49-N were NDUFAB1. When p49-N was used to screen Hela 
cell cDNA library, 8 out of 20 (40%) of the positive clones were NDUFAB1. However, when p49-C was used to screen Hela cell cDNA library, 
none of the clones was NDUFAB1. These results indicate that p49-N selectively binds to NDUFAB1.BMC Cell Biology 2008, 9:8 http://www.biomedcentral.com/1471-2121/9/8
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motifs were located at the N-terminus of the sequence,
including NLS #1 at codons 17–33, and NLS #2 at codons
41–57. NLS #3 is a classic pattern-7 (pat7) NLS motif with
seven amino acid residues (PLLKKKI) at 107–113, and
NLS #4 is a classic pattern-4 NLS motif with four residues
(RRRK) at 408–411. Overall, the intracellular localization
of p49/STRAP was predicted to be 65.2% nuclear, 21.7%
cytoplasmic, 4.3% mitochondrial, 4.3% in vesicles of
secretory system and 4.3% in endoplasmic reticulum
(table 2).
Analysis of NDUFAB1 revealed that NDUFAB1 was esti-
mated to be 78.3% mitochondrial, 8.7% nuclear, 8.7%
cytoplasmic and 4.3% cytoskeletal (table 2).
Intracellular localization of NDUFAB1
NDUFAB1, which is a nuclear-encoded protein, is a subu-
nit of the mitochondrial respiratory Complex I. To visual-
ize the localization of NDUFAB1 in living cells, a red
fluorescent protein (RFP), mCherry, was linked in-frame
with NDUFAB1 and expressed in the H9C2 cells. As
shown in figure 3a, the RFP-NDUFAB1 was observed to be
present in both the cytoplasm and nucleus.
Intracellular localization of p49/STRAP
The EGFP-p49/STRAP expression plasmid was transfected
into H9C2 cells, neonatal cardiac myocytes and NIH3T3
cells. In the un-stimulated H9C2 cells, EGFP-p49/STRAP
fusion protein was observed predominantly within the
nucleus (figures 3c &4a). Nevertheless, in a small subset of
the H9C2 cells, p49/STRAP was also observed in both
nucleus and cytoplasm. Similar results were also observed
in neonatal cardiac myocytes and NIH3T3 cells (data not
shown).
To determine whether the incubation time after transfec-
tion could affect the localization of the p49 protein, cells
were also observed at three time points (24 hours, 48
hours and 72 hours) after transfection. At all three time
points, p49 localized predominantly in the nucleus in the
majority of the cells, with no appreciable relationship
with the time post-transfection (figures 4 and 5). How-
ever, the cytosolic localization of total p49/STRAP did
seem to be slightly related to the degree of confluency (fig-
ure 5).
When H9C2 cells were transfected with both p49/STRAP
and NDUFAB1 expression plasmids, co-localization of
the p49/STRAP and NDUFAB1 proteins was observed (fig-
ure 6).
p49/STRAP expression affected NAD/NADH ratio
NDUFAB1 is a subunit of NADH dehydrogenase that reg-
ulates intracellular NAD, NADH concentrations and the
NAD/NADH ratio. To determine whether the interaction
between p49/STRAP and NDUFAB1 would have any
effect on NADH dehydrogenase activity, thereby affecting
the NAD/NADH ratio, p49/STRAP was delivered into cells
with recombinant adenovirus, and the cycling assay for
NAD/NADH was then performed [15,16]. The results
revealed that NAD concentration was 258 ± 12.4 nM in
control adenovirus treated cells, but 165 ± 15.0 nM in
p49/STRAP adenovirus treated cells; NADH concentration
was 1065 + 15.5 nM in control adenovirus treated cells,
but 1105 ± 24.6 nM in p49/STRAP adenovirus treated
cells. The NAD/NADH ratio was 0.24 ± 0.016 in control
adenovirus treated cells, while 0.14 ± 0.012 in p49/STRAP
adenovirus treated cells. The results indicate that p49/
STRAP adenovirus reduced the intracellular NAD/NADH
ratio by approximately 40% (p < 0.05, n = 4) (figure 7).
Overexpression of p49/STRAP also reduced the acetyla-
tion of SRF (figure 8). These data implicate p49 as an
inducer of SRF deacetylation.
NDUFAB1 binds to p49/STRAP Figure 1
NDUFAB1 binds to p49/STRAP. A. Schematic represen-
tation indicating that NDUFAB1 binds to the N-terminus of 
p49/STRAP protein. B. H9C2 cells were transfected with 
Flag-NDUFAB1 plasmid construct and harvested 24 hours 
later. An anti-IgG antibody (used as a control) and an anti-
p49 antibody were used in the co-immunoprecipitation assay. 
The results show that p49 antibody co-immunoprecipitated 
the endogenous p49 protein and the Flag-NDUFAB1 protein, 
indicating that Flag-NDUFAB1 was bound to endogenous 
p49 protein. C. Flag-NDUFAB1 expression did not change 
p49 protein level in the cells (figure 1c).
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Discussion
The p49/STRAP protein was initially isolated by our group
as a transcription cofactor of SRF, which modulates the
transcriptional regulation of SRF-target genes [1]. In the
present study, we found that p49/STRAP contained four
classic NLS motifs. The p49 protein predominantly local-
ized within the nucleus, but was also present at low levels
in the cytoplasm. In addition, we found that p49/STRAP
interacted with NDUFAB1, a subunit of the mitochon-
drial Complex I which regulates the redox status of NAD/
NADH, and showed that NDUFAB1 could be observed in
both the cytoplasm and nucleus. Furthermore, we found
that overexpression of p49/STRAP altered the intracellular
level of NAD and NADH, and reduced the NAD/NADH
ratio. Overexpression of p49/STRAP also resulted in
reduction of the acetylation of SRF. These results suggest
that via interacting with a component of Complex I, p49/
STRAP plays a role in the regulation of NAD and NADH
which influence fundamental cellular processes such as
cellular metabolism, gene expression, ion channel regula-
tion and possibly aging [17-19].
It is known that Complex I, an enzyme complex that is
located on the inner mitochondrial membrane catalyzes
the transfer of electrons from NADH to coenzyme Q
(CoQ). In the redox process, the complex translocates
electrons across the inner membrane, helping to build the
electrochemical potential used to produce ATP [20]. How-
ever, the exact catalytic mechanism remains incompletely
established. Complex I is the largest respiratory complex,
which contains 46 separate subunits. Of the 46 subunits,
seven are encoded by the mitochondrial genome, while
the rest are encoded by the nuclear genome.
NDUFAB1 is one of the nuclear-encoded subunits of
Complex I, which contains a phosphopantetheine attach-
ment site (DLGLDSLDQVEIIMAM), Characteristic of acyl
carrier proteins. NDUFAB1 also contains an EF-hand cal-
cium binding domain (DIDAEKLMCPQEI) [21]. Deletion
of NDUFAB1 homolog in N. crassa results in impaired
assembly of Complex I and a four-fold increase in lyso-
phospholipid content of mitochondrial membranes, sug-
gesting that NDUFAB1 is required for the assembly of
Complex I, and that it is also involved in fatty acid synthe-
sis [22]. Although NDUFAB1 was considered to be a
membrane bound component of Complex I, recent evi-
dence indicates that soluble NDUFAB1 protein has been
Bioinformatics analysis of p49 sequence Figure 2
Bioinformatics analysis of p49 sequence. Bioinformatics analysis of the sequence of human p49 protein shows that there 
are four classic nuclear localizing sequences (NLS's), three of them are in the N-terminal region. NLS1 & NLS2 are bipartite 
nuclear localization sequences. NLS3 has a pattern-7 motif, and NLS4 has a pattern-4 motif. Blue (residue K or R) indicates 
positively charged (basic) residues, red (residue D or E) indicates negatively charged (acidic) residues. The sections underlined 
in green are highly conserved across human, rat, and mouse.
Table 2: Bioinformatics estimate of intracellular localization 
probability of p49 and NDUFAB1.
Intracellular site p49/STRAP NDUFAB1
Nucleus 65.2% 8.7%
Cytoplasm 21.7% 8.7%
Vesicles of secretory 4.3% 0.0%
Mitochondria 4.3% 78.3%
Endoplasmic reticulum 4.3% 0.0%
Cytoskeleton 0.0% 4.3%
Multiple bioinformatics programs were used to analyze the potential 
intracellular localization of the p49 and NDUFAB1 proteins (see 
details in "Methods"). The results estimate that p49 protein is 
primarily localized within the nucleus, and NDUFAB1 is primarily 
localized in the mitochondria, although both proteins have the 
potential to be in other intracellular compartments as well.BMC Cell Biology 2008, 9:8 http://www.biomedcentral.com/1471-2121/9/8
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found in the mitochondria, suggesting that NDUFAB1
may have other functions [23].
In the present study, NDUFAB1 was identified as a major
binding protein to the p49/STRAP-N region. NDUFAB1
accounted for 95% of the cDNA clones derived from
human heart and 40% of the cDNA clones derived from
human Hela cells, which interacted with the p49-N
region. NDUFAB1 mRNA is expressed in a wide range of
human tissues. The highest expression levels are observed
in adult heart, skeletal muscle and fetal heart [21].
Although majority of the cDNA clones derived from
human heart and Hela cells interacted with the p49-N
region, none of the clones interacted with the p49-C
region. These data suggest that the high binding rate of
NDUFAB1 to p49/STRAP N-terminus is unlikely to be
random, and is unlikely to be associated merely with the
expression level of NDUFAB1 in the tissue origin of the
cDNA library. Rather, this suggests that the NDUFAB1
protein binds selectively to the N-terminus, but not the C-
terminus, of the p49/STRAP protein.
The translocation of a protein from the cytoplasm
through the nuclear pore complex and into the nucleo-
Intracellular localization of p49 and NDUFAB1 Figure 3
Intracellular localization of p49 and NDUFAB1. Fluorescent images of H9C2 cells transfected with NDUFAB1-RFP 
expression plasmids (a, top left) and RFP control (b, top right), demonstrate both nuclear and cytoplasmic distribution. The 
p49-GFP fusion protein appears to be primarily localized within the nucleus, especially the nucleoli (c, bottom left). The GFP-
only control protein is distributed evenly throughout the cells (d, bottom right). GFP = green fluorescent protein; RFP red flu-
orescent protein.BMC Cell Biology 2008, 9:8 http://www.biomedcentral.com/1471-2121/9/8
Page 7 of 11
(page number not for citation purposes)
plasm is usually initiated through the interaction between
an NLS motif on the cargo protein with the NLS motif
binding site on importin-α [24]. The classic nuclear local-
ization sequence generally conform to one of three types,
known as pattern-4 (pat4), pattern-7 (pat7) (both are
monopartite) and bipartite motifs [25-27]. The "pat4"
NLS motif consists of a continuous stretch of four basic
amino acids (lysine or arginine) or three basic amino
acids associated with histidine or proline. The "pat7" NLS
motif starts with a proline and is followed within three
residues by an amino acid sequence containing three basic
residues out of four. The third type of NLS motif, known
as "bipartite" motif, consists of two basic amino acids, a
10 amino acid spacer and a five amino acid sequence con-
taining at least three basic residues [25-27]. All four NLS
motifs of the p49/STRAP protein comply with the classic
definitions of NLS motifs. Our bioinformatic analyses
also suggest that p49/STRAP could potentially localize in
the other cellular compartments; likewise, NDUFAB1 may
also be in the nucleus.
It is well documented that a single gene can give rise to
more than one protein products with different sizes and
with the potential to be localized to different intercellular
compartments. These proteins can be derived from alter-
native splicing, or differential usage of translational initi-
ation signals, thereby containing or lacking specific
compartment targeting signals.
Recent studies indicate that even a single protein product
can have the potential for dual intracellular localization.
For example, wild-type p53 has been observed in cyto-
plasm and nucleus in both normal and tumor cells [28].
p53 protein is accumulated in mitochondria and nuclei of
cardiac myocytes after treatment with Adriamycin [29].
Chronological observation of p53 protein revealed that
upon TPA treatment, p53 was first translocated into mito-
chondria, and then into nucleus [30]. Other examples of
protein with dual localization include BCL2, SRF, ERK,
Myopodin, 14-3-3 proteins, MKP-1 protein, thioredoxin
and BRCA1 [31-38].
It is considered that the localization signal sequence(s) in
proteins play a major role in compartment localization of
the proteins. Proteins that harbor two separate signals or
an overlapping ambiguous signal, and even only one sig-
nal sequence may follow dual distribution in the cell [39].
The mechanism of dual targeting is driven by the compe-
tition of various molecular events. Protein folding, post-
translational modification and protein-protein interac-
tion are key players in this phenomenon [39]. Since pro-
teins are generally considered to be translated in the
cytosol, cytosol may be considered the default compart-
ment for soluble proteins that do not transit to their initial
programmed destination. The p49-N region contains
three NLS motifs. Our data revealed that NDUFAB1 selec-
tively interacted with p49-N region. It is possible that
interaction of p49 with NDUFAB1 and other p49-binding
protein(s) could make the NLS motifs of p49 protein
unaccessible, thereby leading to the retention of p49 in
the cytoplasm, as evidenced by the presence of p49 pro-
tein at low levels in the cytoplasm. Likewise, similar
mechanisms could lead to the retention of NDUFAB1 in
cytoplasm. It is also possible that the interaction between
p49 and NDUFAB1 could retain both proteins within the
Intracellular localization of p49 protein in cultured H9C2  cells Figure 4
Intracellular localization of p49 protein in cultured 
H9C2 cells. Image analyses was performed on more than 
200 H9C2 cells transfected with p49-GFP at 1,2 and 3 days 
after transfection. Cytosolic and nuclear signal intensity of 
p49 was computed using "Image J" program (see description 
in "Methods"). Top Panel: No significant relationship was 
found between p49-GFP cytosolic fraction and day post-
transfection(Day, x axis). Bottom Panel: Images of cells with 
p49-GFP evident in the extranuclear region were measured 
after subtracting the background noise. The images were 
grouped based on the number of days post-transfection. In 
our studies, cell growth displayed a negative quadratic func-
tion during days 1–3 post-transfection (R2adj = 0.273, 
regression not shown).BMC Cell Biology 2008, 9:8 http://www.biomedcentral.com/1471-2121/9/8
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cytoplasm, thus affecting their arrival at their pro-
grammed destination.
A recent study by Lisinski et al. reported that p49/STRAP
is a cytosolic protein and was mainly localized to the cyto-
plasm [40]. Apparently Lisinski and colleagues performed
microscopic analysis on the cells three days after transfec-
tion assay. In the current study, the cells were analyzed at
24 hours, 48 hours and 72 hours after the transfection was
initiated. p49/STRAP protein was observed in the nucleus
in all of cells in which transfection was successful. How-
ever, p49 was present in both nucleus and cytoplasm in a
minority of the cells. In addition, the fraction of total p49
protein accounted for by the cytosolic portion seemed to
decrease, both in absolute value and variability, with the
degree of confluency. Therefore, the differences between
the two groups could be partly due to different culture
conditions. It is also possible that the p49/STRAP protein
could have differing localization under different condi-
tions. Protein modifications including phosphorylation
may also influence nuclear transport of p49/STRAP.
Inasmuch as p49/STRAP interacted with NDUFAB1 and
had an impact on the intracellular NAD/NADH ratio, it is
possible that the interaction affects the assembly of Com-
plex I. Recently, it was reported that the transcription fac-
tor TFII-I plays a role outside the nucleus as an inhibitor
of the cell surface Ca2+ channel TRPC3 by competing for
binding to phospholipase C-g (PLC-g) [41]. Similarly,
p49/STRAP may also play a role outside of the nucleus. It
is also possible that binding of NDUFAB1 by p49/STRAP
could alter the ability of NDUFAB1 to enter mitochondria
and/or could affect the assembling of Complex I, thereby
altering its function and possibly the NAD/NADH ratio.
Statistical indication that only a minority of the p49 protein is observed in the cytoplasm Figure 5
Statistical indication that only a minority of the p49 protein is observed in the cytoplasm. Based on our analyses 
(see detail in the "Methods" section), approximately less than 30% of the protein is located in the cytoplasm. Cells were 
counted using brightfield microscopy and the images were grouped by days post-transfection as shown in figure 4. It is interest-
ing to note that both the absolute value of, and variability in, the cytosolic percent seem to be reduced with increased conflu-
ence in cell count. The absolute residuals were regressed against the cell count, and the resulting function added (+/-) to the 
function of the original regression, resulting in the "band" shown in gray. Taken together, the simple least squares regression 
and residual regression on cell count account for >43% of the variability in cytosolic percent. This implies that p49 is localized 
predominantly in the nucleus. The result is independent of day of culture, and only slightly influenced by degree of cell conflu-
ence.BMC Cell Biology 2008, 9:8 http://www.biomedcentral.com/1471-2121/9/8
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In this study, it was found that overexpression of p49/
STRAP reduced the level of acetylated-SRF protein, sug-
gesting that p49/STRAP may play a role in the regulation
of SRF through the process of acetylation and deacetyla-
tion. Recent studies reveal that reversible acetylation of
non-histone proteins, including transcription factors, play
an important role in the regulation of gene expression.
The reversible acetylation of non-histone proteins is usu-
ally carried out by histone acetyltransferases (HATs) and
histone deacetylases (HDACs). The HATs and HDACs are
often found to be binding proteins of a number of tran-
scription factors and cofactors, and have also been found
to be in protein complexes containing certain transcrip-
tion factors and cofactors [42,43]. In addition, certain
transcription cofactors have been proven to be new mem-
bers of a growing family of acetyltransferases and deacety-
lases)[42-45]. It will be interesting to know the
mechanisms by which p49/STRAP induces the deacetyla-
tion of the SRF protein. It is possible that p49/STRAP may
function as a deacetylase that deacetylates SRF directly. It
is also possible that p49/TRAP change the intracellular
NAD/NADH ratio thereby activating (or recruiting) cer-
tain deacetylase(s) which in turn reduce the level of
acetylated-SRF protein.
Conclusion
The findings in the present study demonstrate that p49/
STRAP regulates intracellular NADH/NAD ratio and SRF
deacetylation. The mechanism of regulation of NADH/
NAD ratio by p49/STRAP is incompletely established at
this time and remains to be further investigated. We plan
to study the mechanism(s) in the future.
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Co-expression of p49 and NDUFAB1 Figure 6
Co-expression of p49 and NDUFAB1. Fluorescent images of H9C2 cells showing uneven distribution p49-EGFP fusion 
protein alone, in green (a) and NDUFAB1-RFP fusion protein alone, in red (b). Co-expression of p49 and NDUFAB1 fusion 
proteins indicates co-localization of these two proteins that appear as yellow in the nuclear region (c). These panels, taken 
together with those of figs. 3a-3d, suggest a more focal localization of p49-GFP compared to control (a, c) in these cells. 
However, for the NDUFAB1-RFP construct (b, c), the distribution usually appears to be more even throughout the cell, simi-
lar to that of GFP-only and RFP-only controls (d, e, f). GFP = green fluorescent protein; RFP = red fluorescent protein.BMC Cell Biology 2008, 9:8 http://www.biomedcentral.com/1471-2121/9/8
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